{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:37:22Z","timestamp":1791153442204,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,3,11]],"date-time":"2014-03-11T00:00:00Z","timestamp":1394496000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Parasitol Res"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1007\/s00436-014-3835-7","type":"journal-article","created":{"date-parts":[[2014,3,10]],"date-time":"2014-03-10T09:25:43Z","timestamp":1394443543000},"page":"1875-1881","source":"Crossref","is-referenced-by-count":54,"title":["Experimental selection of paromomycin and miltefosine resistance in intracellular amastigotes of Leishmania donovani and L. infantum"],"prefix":"10.1007","volume":"113","author":[{"given":"S.","family":"Hendrickx","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Boulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mondelaers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. C.","family":"Dujardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Rijal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Lachaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Cos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Delputte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Maes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,11]]},"reference":[{"key":"3835_CR1","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrmicro1748","volume":"5","author":"F Chappuis","year":"2007","unstructured":"Chappuis F, Sundar S, Hailu A, Ghalib H, Rijal S, Peeling RW, Alvar J, Boelaert M (2007) Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol 5:873\u2013882","journal-title":"Nat Rev Microbiol"},{"key":"3835_CR2","doi-asserted-by":"crossref","first-page":"704","DOI":"10.3201\/eid1804.110841","volume":"18","author":"S Cojean","year":"2012","unstructured":"Cojean S, Houze S, Haouchine D, Huteau F, Lariven S, Hubert V, Michard F, Bories C, Pratlong F, Le BJ, Loiseau PM, Matheron S (2012) Leishmania resistance to miltefosine associated with genetic marker. Emerg Infect Dis 18:704\u2013706","journal-title":"Emerg Infect Dis"},{"key":"3835_CR3","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.trstmh.2008.09.008","volume":"103","author":"RN Davidson","year":"2009","unstructured":"Davidson RN, den Boer M, Ritmeijer K (2009) Paromomycin. Trans R Soc Trop Med Hyg 103:653\u2013660","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"664","key":"3835_CR4","first-page":"664","volume":"106","author":"GP Dhillon","year":"2008","unstructured":"Dhillon GP, Sharma SN, Nair B (2008) Kala-azar elimination programme in India. J Indian Med Assoc 106(664):664\u2013666, 668","journal-title":"J Indian Med Assoc"},{"key":"3835_CR5","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/jac\/dks275","volume":"67","author":"TP Dorlo","year":"2012","unstructured":"Dorlo TP, Balasegaram M, Beijnen JH, de Vries PJ (2012) Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis. J Antimicrob Chemother 67:2576\u20132597","journal-title":"J Antimicrob Chemother"},{"key":"3835_CR6","doi-asserted-by":"crossref","unstructured":"Downing T, Imamura H, Decuypere S, Clark TG, Coombs GH, Cotton JA, Hilley JD, De DS, Maes I, Mottram JC, Quail MA, Rijal S, Sanders M, Schonian G, Stark O, Sundar S, Vanaerschot M, Hertz-Fowler C, Dujardin JC, Berriman M (2011) Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance. Genome Res","DOI":"10.1101\/gr.123430.111"},{"key":"3835_CR7","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.3390\/molecules14072317","volume":"14","author":"F Frezard","year":"2009","unstructured":"Frezard F, Demicheli C, Ribeiro RR (2009) Pentavalent antimonials: new perspectives for old drugs. Molecules 14:2317\u20132336","journal-title":"Molecules"},{"key":"3835_CR8","doi-asserted-by":"crossref","first-page":"e1974","DOI":"10.1371\/journal.pntd.0001974","volume":"6","author":"R Garcia-Hernandez","year":"2012","unstructured":"Garcia-Hernandez R, Manzano JI, Castanys S, Gamarro F (2012) Leishmania donovani develops resistance to drug combinations. PLoS Negl Trop Dis 6:e1974","journal-title":"PLoS Negl Trop Dis"},{"key":"3835_CR9","doi-asserted-by":"crossref","first-page":"e1664","DOI":"10.1371\/journal.pntd.0001664","volume":"6","author":"S Hendrickx","year":"2012","unstructured":"Hendrickx S, da Luz RA I, Bhandari V, Kuypers K, Shaw CD, Lonchamp J, Salotra P, Carter K, Sundar S, Rijal S, Dujardin JC, Cos P, Maes L (2012) Experimental induction of paromomycin resistance in antimony-resistant strains of L. donovani: outcome dependent on in vitro selection protocol. PLoS Negl Trop Dis 6:e1664","journal-title":"PLoS Negl Trop Dis"},{"key":"3835_CR10","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/jac\/dkq444","volume":"66","author":"RA Inocencio da Luz","year":"2011","unstructured":"Inocencio da Luz RA, Vermeersch M, Deschacht M, Hendrickx S, Van AT, Cos P, Maes L (2011) In vitro and in vivo prophylactic and curative activity of the triterpene saponin PX-6518 against cutaneous Leishmania species. J Antimicrob Chemother 66:350\u2013353","journal-title":"J Antimicrob Chemother"},{"key":"3835_CR11","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.1128\/AAC.00866-09","volume":"53","author":"RA Inocencio da Luz","year":"2009","unstructured":"Inocencio da Luz RA, Vermeersch M, Dujardin JC, Cos P, Maes L (2009) In vitro sensitivity testing of Leishmania clinical field isolates: preconditioning of promastigotes enhances infectivity for macrophage host cells. Antimicrob Agents Chemother 53:5197\u20135203","journal-title":"Antimicrob Agents Chemother"},{"key":"3835_CR12","doi-asserted-by":"crossref","first-page":"695382","DOI":"10.1155\/2011\/695382","volume":"2011","author":"F Jeddi","year":"2011","unstructured":"Jeddi F, Piarroux R, Mary C (2011) Antimony resistance in Leishmania, focusing on experimental research. J Trop Med 2011:695382","journal-title":"J Trop Med"},{"key":"3835_CR13","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00436-012-3212-3","volume":"112","author":"A Kulshrestha","year":"2013","unstructured":"Kulshrestha A, Bhandari V, Mukhopadhyay R, Ramesh V, Sundar S, Maes L, Dujardin JC, Roy S, Salotra P (2013) Validation of a simple resazurin-based promastigote assay for the routine monitoring of miltefosine susceptibility in clinical isolates of Leishmania donovani. Parasitol Res 112:825\u2013828","journal-title":"Parasitol Res"},{"key":"3835_CR14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1051\/parasite\/1998052167","volume":"5","author":"M Maarouf","year":"1998","unstructured":"Maarouf M, Adeline MT, Solignac M, Vautrin D, Robert-Gero M (1998) Development and characterization of paromomycin-resistant Leishmania donovani promastigotes. Parasite 5:167\u2013173","journal-title":"Parasite"},{"key":"3835_CR15","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/978-3-7091-1125-3_19","volume-title":"Drug Resistance in Leishmania Parasites","author":"L Maes","year":"2013","unstructured":"Maes L, Cos P, Croft S (2013) The relevance of susceptibility tests, breakpoints and markers. In: Ponte-Sucre A, Diaz E, Padr\u00f3n-Nieves M (eds) Drug Resistance in Leishmania Parasites. Springer, Vienna, pp 407\u2013429"},{"key":"3835_CR16","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1128\/AAC.43.4.727","volume":"43","author":"MP Mingeot-Leclercq","year":"1999","unstructured":"Mingeot-Leclercq MP, Glupczynski Y, Tulkens PM (1999) Aminoglycosides: activity and resistance. Antimicrob Agents Chemother 43:727\u2013737","journal-title":"Antimicrob Agents Chemother"},{"key":"3835_CR17","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1086\/382049","volume":"189","author":"KW Quispe Tintaya","year":"2004","unstructured":"Quispe Tintaya KW, Ying X, Dedet JP, Rijal S, De Bolle X, Dujardin JC (2004) Antigen genes for molecular epidemiology of leishmaniasis: polymorphism of cysteine proteinase B and surface metalloprotease glycoprotein 63 in the Leishmania donovani complex. J Infect Dis 189:1035\u20131043","journal-title":"J Infect Dis"},{"key":"3835_CR18","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/cid\/cit102","volume":"56","author":"S Rijal","year":"2013","unstructured":"Rijal S, Ostyn B, Uranw S, Rai K, Bhattarai NR, Dorlo TP, Beijnen JH, Vanaerschot M, Decuypere S, Dhakal SS, Das ML, Karki P, Singh R, Boelaert M, Dujardin JC (2013) Increasing failure of miltefosine in the treatment of kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance. Clin Infect Dis 56:1530\u20131538","journal-title":"Clin Infect Dis"},{"key":"3835_CR19","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0924-8579(03)00125-0","volume":"22","author":"K Seifert","year":"2003","unstructured":"Seifert K, Matu S, Javier Perez-Victoria F, Castanys S, Gamarro F, Croft SL (2003) Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine). Int J Antimicrob Agents 22:380\u2013387","journal-title":"Int J Antimicrob Agents"},{"key":"3835_CR20","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1365-3156.2001.00778.x","volume":"6","author":"S Sundar","year":"2001","unstructured":"Sundar S (2001) Drug resistance in Indian visceral leishmaniasis. Trop Med Int Health 6:849\u2013854","journal-title":"Trop Med Int Health"},{"key":"3835_CR21","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1056\/NEJMoa021556","volume":"347","author":"S Sundar","year":"2002","unstructured":"Sundar S, Jha TK, Thakur CP, Engel J, Sindermann H, Fischer C, Junge K, Bryceson A, Berman J (2002) Oral miltefosine for Indian visceral leishmaniasis. N Engl J Med 347:1739\u20131746","journal-title":"N Engl J Med"},{"key":"3835_CR22","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1056\/NEJMoa066536","volume":"356","author":"S Sundar","year":"2007","unstructured":"Sundar S, Jha TK, Thakur CP, Sinha PK, Bhattacharya SK (2007) Injectable paromomycin for visceral leishmaniasis in India. N Engl J Med 356:2571\u20132581","journal-title":"N Engl J Med"},{"key":"3835_CR23","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-3156.2007.01974.x","volume":"13","author":"S Sundar","year":"2008","unstructured":"Sundar S, Mondal D, Rijal S, Bhattacharya S, Ghalib H, Kroeger A, Boelaert M, Desjeux P, Richter-Airijoki H, Harms G (2008) Implementation research to support the initiative on the elimination of kala azar from Bangladesh, India and Nepal\u2014the challenges for diagnosis and treatment. Trop Med Int Health 13:2\u20135","journal-title":"Trop Med Int Health"},{"key":"3835_CR24","first-page":"733","volume":"3","author":"S Sundar","year":"2007","unstructured":"Sundar S, Olliaro PL (2007) Miltefosine in the treatment of leishmaniasis: clinical evidence for informed clinical risk management. Ther Clin Risk Manag 3:733\u2013740","journal-title":"Ther Clin Risk Manag"},{"key":"3835_CR25","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/cid\/cis474","volume":"55","author":"S Sundar","year":"2012","unstructured":"Sundar S, Singh A, Rai M, Prajapati VK, Singh AK, Ostyn B, Boelaert M, Dujardin JC, Chakravarty J (2012) Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use. Clin Infect Dis 55:543\u2013550","journal-title":"Clin Infect Dis"},{"key":"3835_CR26","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1473-3099(10)70011-6","volume":"10","author":"J Griensven van","year":"2010","unstructured":"van Griensven J, Balasegaram M, Meheus F, Alvar J, Lynen L, Boelaert M (2010) Combination therapy for visceral leishmaniasis. Lancet Infect Dis 10:184\u2013194","journal-title":"Lancet Infect Dis"},{"key":"3835_CR27","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1128\/AAC.00548-09","volume":"53","author":"M Vermeersch","year":"2009","unstructured":"Vermeersch M, Inocencio da Luz RA, Tote K, Timmermans JP, Cos P, Maes L (2009) In vitro susceptibilities of Leishmania donovani promastigote and amastigote stages to antileishmanial reference drugs: practical relevance of stage-specific differences. Antimicrob Agents Chemother 53:3855\u20133859","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Parasitology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-014-3835-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00436-014-3835-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-014-3835-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T08:50:30Z","timestamp":1565254230000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00436-014-3835-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,11]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["3835"],"URL":"https:\/\/doi.org\/10.1007\/s00436-014-3835-7","relation":{},"ISSN":["0932-0113","1432-1955"],"issn-type":[{"value":"0932-0113","type":"print"},{"value":"1432-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,11]]}}}